首页> 美国卫生研究院文献>BMC Veterinary Research >Cyclooxygenase-2 immunoexpression in intestinal epithelium and lamina propria of cats with inflammatory bowel disease and low grade alimentary lymphoma
【2h】

Cyclooxygenase-2 immunoexpression in intestinal epithelium and lamina propria of cats with inflammatory bowel disease and low grade alimentary lymphoma

机译:炎症性肠病和低度消化道淋巴瘤猫的肠上皮和固有层中环氧合酶-2的免疫表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundCyclooxygenase 2 (COX-2) is an inducible isoform by cellular activation, proinflammatory cytokines and growth factors. The aims of the current study were to evaluate COX-2 immunoexpression in epithelial and lamina propria (LP) of cats with inflammatory bowel disease (IBD) and low grade alimentary lymphoma (LGAL), as well as to correlate them with clinical signs and histopathological scoring. Cats diagnosed with IBD and LGAL (2007–2013) were included in the current study. Feline chronic enteropathy activity index (FCEAI) was calculated for all cases. Control group was composed by 3 healthy indoor cats and 5 sick cats died or were euthanized (non-gastrointestinal illness). Diagnosis and classification of IBD and LGAL was established according to the WSAVA gastrointestinal standardization group template and the National Cancer Institute formulation, respectively. Furthermore, a modified WSAVA template was applied for LGAL evaluation. Immunolabelling for COX-2 (polyclonal rabbit anti-murine antibody) was performed on biopsy samples. Epithelial and LP (inflammatory or neoplastic cells) COX-2 immunolabelling was calculated according to the grade and intensity. The most representative segment scored by the WSAVA and the modified WSAVA were used for statistical analysis.
机译:背景环氧合酶2(COX-2)是通过细胞活化,促炎性细胞因子和生长因子诱导的同工型。本研究的目的是评估患有炎症性肠病(IBD)和低度消化性淋巴瘤(LGAL)的猫的上皮和固有层(LP)的COX-2免疫表达,并将其与临床体征和组织病理学联系起来得分。本研究包括被诊断患有IBD和LGAL(2007-2013)的猫。计算所有病例的猫慢性肠病活性指数(FCEAI)。对照组由3只健康的室内猫组成,有5只患病的猫死亡或被安乐死(非胃肠道疾病)。 IBD和LGAL的诊断和分类分别根据WSAVA胃肠道标准化小组模板和美国国家癌症研究所制定。此外,将修改后的WSAVA模板应用于LGAL评估。在活检样本上进行了COX-2(多克隆兔抗鼠抗体)的免疫标记。根据等级和强度计算上皮和LP(炎性或赘生性细胞)COX-2免疫标记。由WSAVA和改进的WSAVA评分的最具代表性的细分用于统计分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号